Latest News for: amx

Edit

Eielson reactivates the 354th AMXS

Fairbanks Daily News-Miner 11 Jun 2026
EIELSON AIR FORCE BASE — The reactivation of the ...
Edit

Gilde Healthcare company Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia (Gilde Healthcare Partners BV)

Public Technologies 11 Jun 2026
Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for AMX-883, an orally available non-cereblon degrader of BRD9, for the treatment of acute myeloid leukaemia (AML) ... About AMX-883.
Edit

Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader ...

Nasdaq Globe Newswire 08 Jun 2026
AMX-883 is expected to enter the clinic in H2 2026.
Edit

AMX and KASE Sign MoU to Advance Market Connectivity Through Tabadul Hub (Armenia Stock Exchange OJSC)

Public Technologies 02 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132191461) .
Edit

Annual AMX awards 2026 (Armenia Stock Exchange OJSC)

Public Technologies 01 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132157812) .
Edit

Armenia Stock Exchange (AMX) Celebrates Its 25th Anniversary (Armenia Stock Exchange OJSC)

Public Technologies 01 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132149884) .
Edit

Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and ...

Nasdaq Globe Newswire 21 Apr 2026
Cambridge, UK, 21st April 2026 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in ...
  • 1

Article Search

tools
×
×
×
×